Literature DB >> 11750709

Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer.

Francisco R Villegas1, Santiago Coca, Vicente G Villarrubia, Rodrigo Jiménez, María Jesús Chillón, Javier Jareño, Marcos Zuil, Luis Callol.   

Abstract

Natural killer (NK) cells have been implied in the resistance against certain tumors and virally-infected cells. The prognostic significance of tumor infiltrating NK cells in primary squamous cell lung carcinoma (SqCLC) has not been fully studied. Fifty patients with primary SqCLC were evaluated for the presence of tumor infiltrating natural killer cells subset CD57 (TINK) after surgery. None of them received adjuvant therapy. Immunohistochemical studies of surgery pieces were performed by using the monoclonal antibody CD57. The number of TINK cells was counted by using a MICRON image analyzer. The total area studied for each tumor was of 1 cm(2). In this area, 50 intratumoral fields of 0.173 mm(2) were selected. The reference value used was the median (five TINK cells/field) of all tumors analyzed. After a minimum follow-up of 2 years the Kaplan-Meier method was used to obtain survival curves. Multivariate analysis were performed by using the Cox regression model. The survival was significantly better in patients with more than five TINK cells/field (Logrank P=0.0317). According to TNM classification, in those patients screened as stage IB (37 patients) the differences in survival were significantly higher (Logrank P=0.0016). In the multivariate analysis including TNM (surgical-pathologic stage), age, and endoscopy localization, the risk of death in patients with less than five TINK cells/field was 2.50 fold higher (CI 95%; range 1.07-5.85) than in those patients with more than five TINK cells/field. These results show that TINK cells appear to be a prognostic factor in the survival of patients with SqCLC. The possible antitumoral role of these cells in SqCLC is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11750709     DOI: 10.1016/s0169-5002(01)00292-6

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  160 in total

Review 1.  The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.

Authors:  Romain Remark; Christian Becker; Jorge E Gomez; Diane Damotte; Marie-Caroline Dieu-Nosjean; Catherine Sautès-Fridman; Wolf-Herman Fridman; Charles A Powell; Nasser K Altorki; Miriam Merad; Sacha Gnjatic
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

2.  Intratumoral natural killer cells show reduced effector and cytolytic properties and control the differentiation of effector Th1 cells.

Authors:  Sourav Paul; Neeraja Kulkarni; Girdhari Lal
Journal:  Oncoimmunology       Date:  2016-09-20       Impact factor: 8.110

3.  Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab.

Authors:  Alexander Martens; Kilian Wistuba-Hamprecht; Jianda Yuan; Michael A Postow; Phillip Wong; Mariaelena Capone; Gabriele Madonna; Amir Khammari; Bastian Schilling; Antje Sucker; Dirk Schadendorf; Peter Martus; Brigitte Dreno; Paolo A Ascierto; Jedd D Wolchok; Graham Pawelec; Claus Garbe; Benjamin Weide
Journal:  Clin Cancer Res       Date:  2016-05-11       Impact factor: 12.531

4.  Gastric cancer cells inhibit natural killer cell proliferation and induce apoptosis via prostaglandin E2.

Authors:  Tuanjie Li; Qi Zhang; Yuming Jiang; Jiang Yu; Yanfeng Hu; Tingyu Mou; Guihua Chen; Guoxin Li
Journal:  Oncoimmunology       Date:  2015-08-12       Impact factor: 8.110

5.  Cancer-immune equilibrium: questions unanswered.

Authors:  Alka Bhatia; Yashwant Kumar
Journal:  Cancer Microenviron       Date:  2011-05-24

Review 6.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

7.  Shaping of NK cell responses by the tumor microenvironment.

Authors:  Ana Stojanovic; Margareta P Correia; Adelheid Cerwenka
Journal:  Cancer Microenviron       Date:  2012-12-16

8.  Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications.

Authors:  Natalia Lapteva; April G Durett; Jiali Sun; Lisa A Rollins; Leslie L Huye; Jian Fang; Varada Dandekar; Zhuyong Mei; Kimberley Jackson; Juan Vera; Jun Ando; Minhtran C Ngo; Elaine Coustan-Smith; Dario Campana; Susann Szmania; Tarun Garg; Amberly Moreno-Bost; Frits Vanrhee; Adrian P Gee; Cliona M Rooney
Journal:  Cytotherapy       Date:  2012-08-17       Impact factor: 5.414

9.  Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer.

Authors:  Chandra M Ohri; Aarti Shikotra; Ruth H Green; David A Waller; Peter Bradding
Journal:  BMC Cancer       Date:  2010-04-29       Impact factor: 4.430

10.  The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer.

Authors:  Antonino Bruno; Chiara Focaccetti; Arianna Pagani; Andrea S Imperatori; Marco Spagnoletti; Nicola Rotolo; Anna Rita Cantelmo; Francesca Franzi; Carlo Capella; Guido Ferlazzo; Lorenzo Mortara; Adriana Albini; Douglas M Noonan
Journal:  Neoplasia       Date:  2013-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.